In Episode 2 of our 'Tea and Talk' podcast, Dr. Rebekah Widdowfield chats with the CEO of Novabiotics, Dr. Deborah O'Neil about the efficacy of creating drugs, how the vaccine development process works, current efforts being made to produce treatments for COVID-19, and how the current pandemic has affected our approach to global production and collaboration.
Subscribe for a new episode every Friday.
The Royal Society of Edinburgh — @news_RSE
Dr. Rebekah Widdowfield — @Rebekah_RSE
Dr. Deborah O'Neil — @debsoneil | @NovaBiotics
Launching the third series of the RSE’s Tea and Talk Podcast, RSE Chief Executive Rebekah Widdowfield chats with RSE Fellows, Talat Yaqoob and Louise...
We speak to RSE Fellows Professor Maggie Gill and Professor Colin Campbell about land use and climate change. Maggie is Emeritus Professor in the...
Episode 6 of 'Tea and Talk' features Fergus Linehan, Festival Director and CEO of Edinburgh International Festival. Fergus chats to us about the impact...